A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022

Aisling M. Vaughan, Orlando Cenciarelli, Soledad Colombe, Luís Alves de Sousa, Natalie Fischer, Celine M. Gossner, Jeff Pires, Giuditta Scardina, Gudrun Aspelund, Margarita Avercenko, Sara Bengtsson, Paula Blomquist, Anna Caraglia, Emilie Chazelle, Orna Cohen, Asuncion Diaz, Christina Dillon, Irina Dontsenko, Katja Kotkavaara, Mario FafangelFederica Ferraro, Richard Firth, Jannik Fonager, Christina Frank, Mireia G. Carrasco, Kassiani Gkolfinopoulou, Marte Petrikke Grenersen, Bernardo R. Guzmán Herrador, Judit Henczkó, Elske Hoornenborg, Derval Igoe, Maja Ilić, Klaus Jansen, Denisa Georgiana Janță, Tone Bjordal Johansen, Ana Kasradze, Anders Koch, Jan Kyncl, João Vieira Martins, Andrew McAuley, Kassiani Mellou, Zsuzsanna Molnár, Zohar Mor, Joël Mossong, Alina Novacek, Hana Orlikova, Iva Pem Novosel, Maria K. Rossi, Malgorzata Sadkowska-Todys, Clare Sawyer, Daniela Schmid, Anca Sîrbu, Klara Sondén, Arnaud Tarantola, Margarida Tavares, Marianna Thordardottir, Veronika Učakar, Catharina Van Ewijk, Juta Varjas, Anne Vergison, Roberto Vivancos, Karolina Zakrzewska, Richard Pebody, Joana M. Haussig

Research output: Contribution to journalArticlepeer-review

64 Citations (Scopus)
10 Downloads (Pure)


Following the report of a non-travel-associated cluster of monkeypox cases by the United Kingdom in May 2022, 41 countries across the WHO European Region have reported 21,098 cases and two deaths by 23 August 2022. Nowcasting suggests a plateauing in case notifications. Most cases (97%) are MSM, with atypical rash-illness presentation. Spread is mainly through close contact during sexual activities. Few cases are reported among women and children. Targeted interventions of at-risk groups are needed to stop further transmission.

Original languageEnglish
Issue number36
Publication statusPublished - 8 Sept 2022

Bibliographical note

Funding Information: The authors affiliated with the World Health Organization (WHO) are alone responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the WHO. The co-author is a fellow of the ECDC Fellowship Programme, supported financially by the European Centre for Disease Prevention and Control (ECDC). The views and opinions expressed herein do not state or reflect those of ECDC. ECDC is not responsible for the data and information collation and analysis and cannot be held liable for conclusions or opinions drawn.

Open Access: This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence and indicate if changes were made.

Publisher Copyright: This article is copyright of the authors or their affiliated institutions, 2022.

Citation: : Vaughan Aisling M, Cenciarelli Orlando, Colombe Soledad, Alves de Sousa Luís, Fischer Natalie, Gossner Celine M, Pires Jeff, Scardina Giuditta, Aspelund Gudrun, Avercenko Margarita, Bengtsson Sara, Blomquist Paula, Caraglia Anna, Chazelle Emilie, Cohen Orna, Diaz Asuncion, Dillon Christina, Dontsenko Irina, Kotkavaara Katja, Fafangel Mario, Ferraro Federica, Firth Richard, Fonager Jannik, Frank Christina, Carrasco Mireia G, Gkolfinopoulou Kassiani, Grenersen Marte Petrikke, Guzmán Herrador Bernardo R, Henczkó Judit, Hoornenborg Elske, Igoe Derval, Ilić Maja, Jansen Klaus, Janță Denisa-Georgiana, Johansen Tone Bjordal, Kasradze Ana, Koch Anders, Kyncl Jan, Martins João Vieira, McAuley Andrew, Mellou Kassiani, Molnár Zsuzsanna, Mor Zohar, Mossong Joël, Novacek Alina, Orlikova Hana, Pem Novosel Iva, Rossi Maria K, Sadkowska-Todys Malgorzata, Sawyer Clare, Schmid Daniela, Sîrbu Anca, Sondén Klara, Tarantola Arnaud, Tavares Margarida, Thordardottir Marianna, Učakar Veronika, Van Ewijk Catharina, Varjas Juta, Vergison Anne, Vivancos Roberto, Zakrzewska Karolina, Pebody Richard, Haussig Joana M. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill. 2022;27(36):pii=2200620. https://doi.org/10.2807/1560-7917.ES.2022.27.36.2200620

DOI: https://doi.org/10.2807/1560-7917.ES.2022.27.36.2200620


Dive into the research topics of 'A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022'. Together they form a unique fingerprint.

Cite this